Skip to main content

Day: May 13, 2025

Consolidated Water Receives Key Approval for $204 Million Seawater Desalination Plant Project in Hawaii

GEORGE TOWN, Cayman Islands, May 13, 2025 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported that its wholly owned subsidiary, Kalaeloa Desalco LLC, recently achieved a major milestone for its $204 million project to design, construct, operate and maintain a 1.7 million gallon per day seawater desalination plant in Hawaii. The Honolulu Board of Water Supply, the client for the multi-year project that commenced in June 2023, approved the pilot test reports and recommendations submitted by Kalaeloa Desalco. The Board concluded that the desalinated water the company produced during the piloting phase is a reasonable match to their existing water supply. They also concluded that the desalinated water from...

Continue reading

Helport AI Launches Helport Remote to Redefine Global Contact Center Management

AI-Powered Workforce Monitoring Tool Developed for Large-Scale, Global Operations Targets Rapidly Expanding Remote Customer Service Industry New Offering Pioneers Intelligent Time Management, Video Monitoring, and Performance Insights Across Borders SINGAPORE and MANILA, Philippines and SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology company serving enterprise clients with intelligent customer communication software and services, today announced the launch of Helport Remote, a new workforce monitoring and management tool designed to support the evolving needs of remote contact centers. Engineered specifically for large-scale, multinational contact center operations, Helport Remote aims to empower management teams to achieve greater visibility, control,...

Continue reading

Hudson Global Reports 2025 First Quarter Results

OLD GREENWICH, Conn., May 13, 2025 (GLOBE NEWSWIRE) — Hudson Global, Inc. (Nasdaq: HSON) (“Hudson Global” or “the Company”), a leading global total talent solutions company, announced today financial results for the first quarter ended March 31, 2025. 2025 First Quarter SummaryRevenue of $31.9 million decreased 6.0% from the first quarter of 2024 and 3.3% in constant currency. Adjusted net revenue of $16.4 million increased 0.4% from the first quarter of 2024 and 2.2% in constant currency. Net loss was $1.8 million, or $0.59 per diluted share, compared to net loss of $2.9 million, or $0.95 per diluted share, for the first quarter of 2024. Adjusted net loss per diluted share (non-GAAP measure)* was $0.46 compared to adjusted net loss per diluted share of $0.72 in the first quarter of 2024. Adjusted EBITDA...

Continue reading

ParaZero Secures New European Order for SafeAir M4 Systems, Expanding Presence in Innovative Drone Market

TEL AVIV, Israel, May 13, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense counter-UAS systems, today announced a follow-on purchase order for its innovative SafeAir™ M4 parachute recovery system from a prominent drone technology partner in Europe. This order reflects ParaZero’s growing traction in Europe’s dynamic drone market, a hub for advanced unmanned aerial systems (UAS) in logistics, infrastructure inspection, and public safety. The SafeAir™ M4, ParaZero’s next-generation autonomous parachute recovery system, is designed for seamless integration with DJI’s Matrice 4 series. It features real-time telemetry and is designed and expected to comply with the highest European...

Continue reading

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

Addresses key challenges for CAR-T therapies Potential to significantly reduce costs and improve clinical efficacy of engineered effector T cells Data Shared at 2025 Annual Meeting of American Association of Immunologists MIRAMAR, Fla., May 13, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by targeting the link between chronic inflammation and disease, announced today presentation of studies showing that its proprietary fusion protein, HCW9206, provides a new pathway for generating chimeric T-cell receptor – T cells (CAR-Ts) for immunotherapy with increased function. HCW9206 is a novel class of immunotherapeutic that enables a single molecule to...

Continue reading

CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors

Survival observations in mTNBC patients correlated with increased PD-L1 expression Preliminary evidence suggests leronlimab has potential to turn “cold” tumors “hot” VANCOUVER, Washington, May 13, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced new data suggesting a novel mechanism of action of leronlimab for the treatment of solid tumors. CytoDyn analyzed data from its prior clinical trials of patients with metastatic Triple-Negative Breast Cancer (“mTNBC”) and found that leronlimab treatment correlated with increased expression of an immune cell protein or “checkpoint inhibitor” known as programmed death-ligand 1 (“PD-L1”) on patient’s...

Continue reading

Greif Receives Supplier Innovation Award from the U.S. Postal Service

DELAWARE, Ohio, May 13, 2025 (GLOBE NEWSWIRE) — Greif (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, is proud to announce it has been awarded the Supplier Innovation Award by the United States Postal Service (USPS). The Supplier Innovation Award celebrates partners who deliver creative, value-driven solutions that extend beyond contractual obligations. Greif earned this distinction for its part in introducing a custom double-walled corrugated pallet box to replace traditional USPS bulk containers. Manufactured with renewable and recyclable materials, the new lighter-weight box is projected to deliver substantial cost reductions to the USPS—and savings to U.S. taxpayers. “Being recognized by the USPS, one of the nation’s most critical public service organizations, is an incredible honor,”...

Continue reading

KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the First Quarter of 2025

MISSISSAUGA, Ontario, May 13, 2025 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX:KPT), which holds an interest in Kruger Products Inc., will release the financial results for KPT and Kruger Products Inc. for the first quarter of 2025 on Wednesday, May 14, 2025 before the market opens. KPT will hold its conference call the same day at 8:30 a.m. Eastern Time. Conference Call InformationVia telephone: 1-888-699-1199 or 416-945-7677Via internet: www.kptissueinc.com Presentation material referenced during the conference call will be available at www.kptissueinc.com. Conference Call RebroadcastA rebroadcast of the conference call will be available until midnight, May 21, 2025 by dialing 1-888-660-6345 or 289-819-1450 and entering passcode 89122. The replay of the webcast will remain available on the website until midnight, May 21, 2025. About...

Continue reading

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study

Milestone Achieved as Adovate Initiates First-in-Human Study for Novel Asthma Therapy Targeting Underserved, Multi-Billion Dollar Market Glen Allen, Va., May 13, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has received a six-figure development milestone payment from Adovate, LLC, following the commencement of a Phase 1 clinical trial evaluating Adovate’s lead compound for asthma, ADO-5030. This milestone payment follows Adovate’s exercise of its option to acquire the assets and business of Purnovate, Inc., a wholly owned subsidiary of Adial Pharmaceuticals, as previously disclosed. The ongoing Phase 1 study is a...

Continue reading

Workhorse Expands National Dealer Network with New Locations in Washington and Wisconsin

Range Truck Group joins as key Pacific Northwest partner; third Midwest Ziegler Truck Group location added CINCINNATI, May 13, 2025 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced the expansion of its partnership with Ziegler Truck Group, adding two new dealer locations to its national network. Range Truck Group, located in Fife, Washington, joins the Workhorse dealer family as a key addition in a region leading the charge in electric vehicle adoption. A partner to Ziegler Truck Group, Range specializes in zero-emission commercial vehicles and charging solutions. Its addition enhances Workhorse’s presence in the Pacific Northwest, where demand for reliable, electric last-mile...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.